Search

The Gerstner Sloan Kettering Summer Undergraduate Research Program has welcomed 24 students to Sloan Kettering Institute labs for a ten-week course of study mentored by GSK faculty.

… Wednesday, June 11, 2014 The 2014 Gerstner Sloan Kettering Summer Undergraduate Research Program (SURP) , which will run from June 2 to August 8, includes 24 students from 21 different institutions. The students are assigned to GSK faculty mentors and will work in Sloan Kettering Institute labs learning

Hear from Abby Wood, a survivor of Hodgkin lymphoma, who is now giving back to MSK through fundraising with Cycle for Survival.

… Friday, September 28, 2018 Summary This story originally appeared in Bridges, MSK’s newsletter for cancer survivors. Bridges offers a forum in which patients and their families can share stories of inspiration and hope, and of the challenges that can accompany a cancer journey. Learn more about how to

New MSK research uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available contrast dye could help surgeons better separate cancer from healthy tissue.

… Wednesday, September 18, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available

Discover the role of the work environment in the life and career of an employee with cancer.

… Wednesday, February 8, 2017 Summary Breast cancer patients who worked for supportive employers were more likely to hang onto their jobs after treatment than women who didn’t, according to a new study led by Memorial Sloan Kettering medical oncologist Victoria Blinder . Hear how one woman navigated life

An international team of researchers led by Sandra Misale, research associate at the Sloan Kettering Institute, examined the effects of the experimental cancer drug, AMG510, which targets KRAS G12C cell lines, and found that the efficacy of such KRAS G12C inhibitors is lineage-specific. These findings provide a mechanistic understanding of the differences in response to KRAS G12C inhibitor in lung and colorectal cancers.

… Tuesday, May 19, 2020 Background KRAS is one of the most commonly mutated genes in human tumors, including lung, colon and pancreatic cancers. Mutant KRAS has been considered undruggable for decades until the recent development of a new class of covalent inhibitors that are able to inhibit the G12C mutant

Memorial Sloan Kettering Cancer Center (MSK) has been recognized by the American College of Surgeons (ACS) for its commitment to providing optimal surgical care for children and adolescents.

… Tuesday, March 14, 2023 Memorial Sloan Kettering Cancer Center (MSK) has been recognized by the American College of Surgeons (ACS) for its commitment to providing optimal surgical care for children and adolescents. It is the first hospital in the nation to receive the ACS’ Children’s Surgery Verification

Learn how Randy Reif got state-of-the-art care for a benign brain tumor at Memorial Sloan Kettering Cancer Center.

… Wednesday, February 16, 2022 Police officer Randy Reif was trained to handle almost any situation. But nothing could have prepared him for the fight of his life. Randy woke up one day in October 2021 feeling lightheaded. He also noticed changes in his vision. Before long, Randy was on the floor, having

A team of experts at MSK shared their insights on managing blood cancer or a bone marrow transplant in a recent Information Session.

… Monday, June 15, 2020 Concerns around COVID-19 are common in the general population, but cancer patients are also balancing questions about what the pandemic means for their treatment, prognosis, and vulnerability to the virus.  A team of experts at MSK shared their insights on this topic in an Information

Scott W. Lowe has joined Memorial Sloan Kettering Cancer Center as a member of the Cancer Biology and Genetics Program in the Sloan Kettering Institute and Chair of the Geoffrey Beene Cancer Research Center.

… Saturday, October 1, 2011 Summary Scott W. Lowe has joined Memorial Sloan Kettering Cancer Center as a member of the Cancer Biology and Genetics Program in the Sloan Kettering Institute and Chair of the Geoffrey Beene Cancer Research Center. Scott W. Lowe has joined Memorial Sloan Kettering Cancer Center

A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells.

… Thursday, December 1, 2011 Summary A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells. A multidisciplinary team from Memorial Sloan Kettering Cancer Center has published research suggesting a potential